title: Utility of FDG-PET/CT in the follow-up of neuroblastoma which became MIBG-negative.
authors.forename: Heather
authors.initials: H
authors.lastname: Mc Dowell
authors.forename: Paul
authors.initials: P
authors.lastname: Losty
authors.forename: Nik
authors.initials: N
authors.lastname: Barnes
authors.forename: George
authors.initials: G
authors.lastname: Kokai
mesh_terms: D019797:3-Iodobenzylguanidine; D000310:Adrenal Gland Neoplasms / Q000000981:diagnostic imaging* / Q000628:therapy; D000970:Antineoplastic Agents / Q000008:administration & dosage; D003131:Combined Modality Therapy; D013507:Endocrine Surgical Procedures; D005260:Female; D019788:Fluorodeoxyglucose F18; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging; D009447:Neuroblastoma / Q000000981:diagnostic imaging* / Q000628:therapy; D049268:Positron-Emission Tomography / Q000379:methods; D019275:Radiopharmaceuticals; D011878:Radiotherapy; D014057:Tomography, X-Ray Computed / Q000379:methods
chemical_list: D000970:Antineoplastic Agents; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D019797:3-Iodobenzylguanidine